14 February 2022
Life | Collection of Melanoma Papers
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
“Novel Methylation Patterns Predict Outcomes in Uveal Melanoma”
Sarah Tadhg Ferrier et al.
Life 2020, 10, 248; 10.3390/life9030067
Available online: https://doi.org/10.3390/life10100248
“Treatment of Advanced Melanoma: Past, Present, and Future”
Taku Fujimura et al.
Life 2020, 10, 208; 10.3390/life10090208
Available online: https://doi.org/10.3390/life10090208
“SOX11, SOX10, and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma”
Marius-Alexandru Beleaua et al.
Life 2021, 11, 281; 10.3390/life11040281
Available online: https://doi.org/10.3390/life11040281
“Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy”
Ilaria Proietti et al.
Life 2021, 11, 692; 10.3390/life11070692
Available online: https://doi.org/10.3390/life11070692
“Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced Melanoma”
Devayani Machiraju et al.
Life 2021, 11, 1318; 10.3390/life11121318
Available online: https://doi.org/10.3390/life11121318
“Cancer Stem Cells in Head and Neck Metastatic Malignant Melanoma Express Components of the Renin–Angiotensin System”
Sam Siljee et al.
Life 2020, 10, 268; 10.3390/life10110268
Available online: https://doi.org/10.3390/life10110268
“Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival”
Malgorzata Gajdzis et al.
Life 2020, 10, 225; 10.3390/life10100225
Available online: https://doi.org/10.3390/life10100225
“Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis”
Chiao-En Wu et al.
Life 2020, 10, 276; 10.3390/life10110276
Available online: https://doi.org/10.3390/life10110276
“Hippo Signaling Pathway as a New Potential Target in Non-Melanoma Skin Cancers: A Narrative Review”
Igor Aleksander Bednarski et al.
Life 2021, 11, 680; 10.3390/life11070680
Available online: https://doi.org/10.3390/life11070680
“Structure, Activity, and Function of the SETDB1 Protein Methyltransferase”
Mariam Markouli et al.
Life 2021, 11, 817; 10.3390/life11080817
Available online: https://doi.org/10.3390/life11080817